BE842796A - Procede de preparation de vaccins de virus - Google Patents
Procede de preparation de vaccins de virusInfo
- Publication number
- BE842796A BE842796A BE167794A BE167794A BE842796A BE 842796 A BE842796 A BE 842796A BE 167794 A BE167794 A BE 167794A BE 167794 A BE167794 A BE 167794A BE 842796 A BE842796 A BE 842796A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation process
- virus vaccine
- vaccine preparation
- virus
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752525733 DE2525733A1 (de) | 1975-06-10 | 1975-06-10 | Verfahren zur herstellung von virusvaccinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE842796A true BE842796A (fr) | 1976-12-10 |
Family
ID=5948685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE167794A BE842796A (fr) | 1975-06-10 | 1976-06-10 | Procede de preparation de vaccins de virus |
Country Status (14)
| Country | Link |
|---|---|
| AR (1) | AR208012A1 (fr) |
| AT (1) | AT362495B (fr) |
| BE (1) | BE842796A (fr) |
| BR (1) | BR7603715A (fr) |
| DE (1) | DE2525733A1 (fr) |
| DK (1) | DK254876A (fr) |
| ES (1) | ES448573A1 (fr) |
| FR (1) | FR2314252A1 (fr) |
| GB (1) | GB1548258A (fr) |
| IE (1) | IE43380B1 (fr) |
| IN (1) | IN141155B (fr) |
| IT (1) | IT1061406B (fr) |
| LU (1) | LU75106A1 (fr) |
| NL (1) | NL7606074A (fr) |
-
1975
- 1975-01-01 AR AR26155175A patent/AR208012A1/es active
- 1975-06-10 DE DE19752525733 patent/DE2525733A1/de not_active Ceased
-
1976
- 1976-06-04 NL NL7606074A patent/NL7606074A/xx not_active Application Discontinuation
- 1976-06-04 ES ES448573A patent/ES448573A1/es not_active Expired
- 1976-06-08 IN IN986/CAL/1976A patent/IN141155B/en unknown
- 1976-06-08 LU LU75106A patent/LU75106A1/xx unknown
- 1976-06-08 IT IT2405376A patent/IT1061406B/it active
- 1976-06-09 AT AT420076A patent/AT362495B/de not_active IP Right Cessation
- 1976-06-09 DK DK254876A patent/DK254876A/da unknown
- 1976-06-09 IE IE123476A patent/IE43380B1/en unknown
- 1976-06-10 FR FR7617593A patent/FR2314252A1/fr active Granted
- 1976-06-10 BE BE167794A patent/BE842796A/fr not_active IP Right Cessation
- 1976-06-10 GB GB2405676A patent/GB1548258A/en not_active Expired
- 1976-06-10 BR BR7603715A patent/BR7603715A/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU75106A1 (fr) | 1977-03-09 |
| NL7606074A (nl) | 1976-12-14 |
| GB1548258A (en) | 1979-07-11 |
| ES448573A1 (es) | 1977-07-16 |
| DK254876A (da) | 1976-12-11 |
| DE2525733A1 (de) | 1976-12-16 |
| IN141155B (fr) | 1977-01-22 |
| ATA420076A (de) | 1980-10-15 |
| AR208012A1 (es) | 1976-11-22 |
| IE43380B1 (en) | 1981-02-11 |
| IE43380L (en) | 1976-12-10 |
| FR2314252A1 (fr) | 1977-01-07 |
| FR2314252B1 (fr) | 1980-01-25 |
| BR7603715A (pt) | 1977-02-01 |
| IT1061406B (it) | 1983-02-28 |
| AT362495B (de) | 1981-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE858992A (fr) | Procede de preparation de vaccins | |
| FR2323435A1 (fr) | Procede de preparation de dis | |
| SE7604818L (sv) | Vaccin | |
| BE839347A (fr) | Procede de preparation de nouvelles indolyalcoylpiperidines | |
| FR2302379A1 (fr) | Procede de preparation de | |
| FR2317262A1 (fr) | Procede de preparation de thymol | |
| BE840540A (fr) | Procede de preparation de sterol-glycosides aisement absorbables | |
| AU1606576A (en) | Rabies virus vaccine processes | |
| BE824372A (fr) | Vaccins antigrippaux et procede de leur preparation | |
| FR2327987A1 (fr) | Procede de preparation de 4-alkyl-thiosemicarbazides | |
| BE839004A (fr) | Procede de preparation de 4-oxo-hexahydropyrazino-isoquinoleine | |
| FR2302315A1 (fr) | Procede de preparation de polyesters modifies p | |
| FR2329625A1 (fr) | Procede de preparation de trichloromethyltrifluoromethylbenzene | |
| FR2325656A1 (fr) | Procede de preparation de chlorophosphites | |
| FR2298614A1 (fr) | Procede de preparation de n-(a-alcoxyethyl)-carboxamides | |
| FR2345425A1 (fr) | Procede de preparation de 4-acylaminoanthrones | |
| FR2327980A1 (fr) | Procede de preparation de trimethylhydroquinone | |
| BE821175A (fr) | Preparation de vaccins a fragments de virus apyretogenes | |
| BE831786A (fr) | Vaccin contre la gravidite et procede de sa preparation | |
| BE845980A (fr) | Procede de preparation de polypropylene-polyamines | |
| FR2314252A1 (fr) | Procede de preparation de vaccins de virus | |
| FR2298537A1 (fr) | Procede de preparation de sulfonylurees | |
| BE846666A (fr) | Procede de preparation de copolymeres | |
| BE840423A (fr) | Procede de preparation de supports de magnetogramme | |
| BE843953A (fr) | Procede de preparation de gamma-pyrones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: BEHRINGWERKE A.G. Effective date: 19840610 |